Reducing Brain Edema Using Berotralstat, an Inhibitor of Bradykinin, Repurposed as Treatment Adjunct in Glioblastoma
Glioblastomas synthesize, bear receptors for, and respond to bradykinin, triggering migration and proliferation. Since centrifugal migration into uninvolved surrounding brain tissue occurs early in the course of glioblastoma, this attribute defeats local treatment attempts and is the primary reason...
Saved in:
| Main Author: | Richard E. Kast |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-07-01
|
| Series: | Neuroglia |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2571-6980/5/3/16 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Escin’s Action on Bradykinin Pathway: Advantageous Clinical Properties for an Unknown Mechanism?
by: Gianmarco Marcianò, et al.
Published: (2024-09-01) -
Alzheimer’s Disease: In Vitro and In Vivo Evidence of Activation of the Plasma Bradykinin-Forming Cascade and Implications for Therapy
by: Allen P. Kaplan, et al.
Published: (2024-12-01) -
Bradykinin’s carbamylation as a mechanistic link to impaired wound healing in patients with kidney dysfunction
by: Marta Kaminska, et al.
Published: (2025-03-01) -
Analysis of prodromal symptoms and need for short-term prophylaxis in angioedema patients under long-term prophylaxis
by: Robin Lochbaum, et al.
Published: (2025-02-01) -
Integrated Workflow for Drug Repurposing in Glioblastoma: Computational Prediction and Preclinical Validation of Therapeutic Candidates
by: Nazareno Gonzalez, et al.
Published: (2025-06-01)